Materialise/$MTLS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Materialise
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
Ticker
$MTLS
Sector
Software & Cloud Services
Primary listing
Employees
488
Headquarters
Website
Materialise Metrics
BasicAdvanced
$361M
57.91
$0.11
1.25
-
Price and volume
Market cap
$361M
Beta
1.25
52-week high
$9.69
52-week low
$3.93
Average daily volume
161K
Financial strength
Current ratio
2.16
Quick ratio
1.781
Long term debt to equity
17.252
Total debt to equity
21.518
Interest coverage (TTM)
1.08%
Profitability
EBITDA (TTM)
24.76
Gross margin (TTM)
56.55%
Net profit margin (TTM)
2.12%
Operating margin (TTM)
2.40%
Effective tax rate (TTM)
-22.32%
Revenue per employee (TTM)
$632,510
Management effectiveness
Return on assets (TTM)
0.99%
Return on equity (TTM)
2.28%
Valuation
Price to earnings (TTM)
57.911
Price to revenue (TTM)
1.16
Price to book
1.45
Price to tangible book (TTM)
2.02
Price to free cash flow (TTM)
274.368
Free cash flow yield (TTM)
0.36%
Free cash flow per share (TTM)
0.022
Growth
Revenue change (TTM)
2.98%
Earnings per share change (TTM)
-51.46%
3-year revenue growth (CAGR)
6.44%
10-year revenue growth (CAGR)
11.24%
3-year earnings per share growth (CAGR)
-28.40%
10-year earnings per share growth (CAGR)
9.39%
What the Analysts think about Materialise
Analyst ratings (Buy, Hold, Sell) for Materialise stock.
Bulls say / Bears say
The Materialise Medical segment posted strong 16.7% revenue growth in Q2 2025, now making up over half of total revenue and highlighting the resilience of its premium medical software and device products (Business Wire)
Gross profit margin rose to 58.3% in Q2 2025 from 57.0% a year ago, thanks to tighter cost management and a greater share of high-margin medical sales (Business Wire)
Net cash position improved by €2.025 million to €63.045 million as of June 30, 2025, powered by positive free cash flow and strengthening liquidity for potential strategic moves (SEC EDGAR)
Materialise’s Manufacturing segment revenue dropped 24.9% year-on-year in Q2 2025, pulling total revenue lower due to continued macroeconomic challenges (Business Wire)
Adjusted EBIT for Q2 2025 decreased to €3.06 million from €3.87 million year-on-year, as the adjusted EBIT margin narrowed to 4.7% from 5.6%, indicating added pressure on profitability (Business Wire)
Management cut full-year 2025 revenue guidance to a range of €265 million–€280 million, down from the earlier €270 million–€285 million outlook, signaling caution in light of ongoing geopolitical tensions and currency risks (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2025.
Materialise Financial Performance
Revenues and expenses
Materialise Earnings Performance
Company profitability
Materialise News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Materialise stock?
Materialise (MTLS) has a market cap of $361M as of October 17, 2025.
What is the P/E ratio for Materialise stock?
The price to earnings (P/E) ratio for Materialise (MTLS) stock is 57.91 as of October 17, 2025.
Does Materialise stock pay dividends?
No, Materialise (MTLS) stock does not pay dividends to its shareholders as of October 17, 2025.
When is the next Materialise dividend payment date?
Materialise (MTLS) stock does not pay dividends to its shareholders.
What is the beta indicator for Materialise?
Materialise (MTLS) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.